Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon V Tiu

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.
Leukemia & Lymphoma|October 21, 2014
Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemiaValeria Visconte, Ali Tabarroki, Christopher J Gerace, et al.
Leukemia & Lymphoma|January 8, 2015
Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapyMoshe C Ornstein, Sudipto Mukherjee, Michael Keng, et al.
Genes, Chromosomes & Cancer|January 23, 2010
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysisJungwon Huh, Ramon V Tiu, Lukasz P Gondek, et al.
American Journal of Hematology|July 6, 2013
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weightCandice M Wenzell, Erika M Gallagher, Marc Earl, et al.
Haematologica|May 25, 2011
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemiaManuel G Afable, Mohammed Shaik, Yuka Sugimoto, et al.
Journal of Hematology & Oncology|December 8, 2014
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblastsValeria Visconte, Ali Tabarroki, Li Zhang, et al.
The Journal of Clinical Investigation|October 5, 2013
Pak and Rac GTPases promote oncogenic KIT-induced neoplasmsHolly Martin, Raghuveer Singh Mali, Peilin Ma, et al.
Haematologica|July 9, 2013
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotypeValeria Visconte, Ali Tabarroki, Heesun J Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemiaRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.
Leukemia & Lymphoma|October 21, 2014
Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemiaValeria Visconte, Ali Tabarroki, Christopher J Gerace, et al.
Leukemia & Lymphoma|January 8, 2015
Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapyMoshe C Ornstein, Sudipto Mukherjee, Michael Keng, et al.
Genes, Chromosomes & Cancer|January 23, 2010
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysisJungwon Huh, Ramon V Tiu, Lukasz P Gondek, et al.
American Journal of Hematology|July 6, 2013
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weightCandice M Wenzell, Erika M Gallagher, Marc Earl, et al.
Haematologica|May 25, 2011
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemiaManuel G Afable, Mohammed Shaik, Yuka Sugimoto, et al.
Journal of Hematology & Oncology|December 8, 2014
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblastsValeria Visconte, Ali Tabarroki, Li Zhang, et al.
The Journal of Clinical Investigation|October 5, 2013
Pak and Rac GTPases promote oncogenic KIT-induced neoplasmsHolly Martin, Raghuveer Singh Mali, Peilin Ma, et al.
Haematologica|July 9, 2013
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotypeValeria Visconte, Ali Tabarroki, Heesun J Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemiaRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Pageof 9